Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effecti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Therap Adv Gastroenterol
Autors principals: Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, Yang, Tian
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720303/
https://ncbi.nlm.nih.gov/pubmed/33329759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820977693
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars